~ Company also ranked amongst 100 Best Companies for Women twice in a row
Mumbai, 3rd Nov, 2023: Thermo Fisher Scientific in India has once again been recognized with two prestigious awards, strengthening its position as a leading workplace in the country. The company has been certified as a Great Place to Work by the Great Place to Work Institute for the fifth consecutive year and ranked among the 100 Best Companies for Women in India for the second year in a row by Avtar and Seramount.
Key senior appointment to drive research and development activities for portfolio of PhysioMimix OOC microphysiological systems
Cambridge, UK, 02 November 2023: CN Bio, a leading Organ-on-a-Chip (OOC) company that designs and manufactures single-and multi-organ microphysiological systems (MPS), today announced it has appointed Neil Rumbelow as Director of Product Development.
Arecor Therapeutics plc
(“Arecor” or the “Company”)
INHIBRX MILESTONE TRIGGERS PAYMENT TO ARECOR UNDER LICENSE AGREEMENT
Cambridge, UK, 2 November 2023. Arecor Therapeutics plc (AIM: AREC), the biopharmaceutical company advancing today’s therapies to enable healthier lives, announces the triggering of a milestone payment from Inhibrx Inc. (“Inhibrx”), for a novel enhanced formulation of INBRX-101, developed by Arecor using the Company’s patented technology, Arestat™, under a license agreement entered into by the two companies in December 2020.
United Kingdom, 1st November 2023 - The experienced life science logistics company, Biocair, provides critical logistics support to a cutting-edge research project into drugs that can treat, and prevent, one of the world’s more serious medical conditions, fibrosis.
Tokyo, Japan and Cambridge, UK, 31 October 2023 – Sosei Group Corporation (“Sosei Heptares” or “the Company”; TSE: 4565) will receive a US$3.75 million milestone payment under the 2019 multi-target Research Collaboration and License Agreement with Genentech, a member of the Roche Group. The discovery-based payment is related to progression of a potential first-in-class project targeting an undisclosed G protein-coupled receptor (“GPCR”). Genentech will now be responsible for further development and commercialization of this potential new medicine.
They have designed ioCRISPR-Ready Cells to significantly reduce the time investment required to produce gene knockouts and run CRISPR screens in human iPSC-derived cells. READ MORE
CCDC extends its partnership with Orgmento, a Ghanaian software engineering and data sciences company.
The partnership, which started in 2021, has been strengthened by the shared commitment to engineering excellence from both organizations, and has now been extended for a further 3 years.
Software engineering teams from the CCDC and Orgmento will build software to advance structural science.
Cambridge, UK. 31 October 2023
The October issue of our monthly People Pathways newsletter is now available to read here!
Cambridge, UK, October 12, 2023 – Mestag Therapeutics (“Mestag”), a biotech company harnessing new insights into fibroblast-immune interactions to develop impactful treatments for patients, today announced the appointment of expert advisors Dr. Cassandra Choe-Juliak MD, formerly Chief Medical Officer at Flame Biosciences; Dr. Greg Elson, an expert in end-to-end development of novel antibody-based products with more than 30 years of industry experience; and Samantha Vieira MBA PMP, formerly Chief Operating Officer at Anjarium Biosciences.